The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience
These findings challenge the assumption that pretreatment characteristics are major determinants of the acute psychedelic experience. While some traits may modestly modulate aspects of the experience, dose remains the largest driver.
Authors
- Guy M. Goodwin (ORCID: https://orcid.org/0000-0002-1426-2816)
- Michael Gold (ORCID: https://orcid.org/0000-0002-4410-1669)
- Namik Kirlić (ORCID: https://orcid.org/0000-0003-4153-8774)
- Merve Atli
- Sunil Mistry
Institutions
- Pathfinder International (US)
- Mind (GB)
Publication Details
- Journal
- Journal of Clinical Psychopharmacology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1097/jcp.0000000000002119
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00